Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Novartis Ord Shs NVSEF

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.


OTCPK:NVSEF - Post by User

<< Previous
Bullboard Posts
Post by Imarcgroupon Sep 14, 2022 3:33am
396 Views
Post# 34961049

Japan Biocatalyst Market Research Report 2027

Japan Biocatalyst Market Research Report 2027

According to IMARC Group’s latest report, titled “Japan Biocatalyst Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’ the Japan biocatalyst market size reached 5.26 Kilo Tons in 2021. Looking forward, IMARC Group expects the market to reach 8.28 Kilo Tons by 2027, expanding at a CAGR of 7.77% during the forecast period 2022-2027. Biocatalysts refer to microbes or enzymes that are usually present in living organisms, such as microorganisms, animals and plants. They are generally utilized to initiate or catalyze the conversion of organic compounds and chemical reactions in a living body. Additionally, they are also used in the production of antibodies, vitamins, statins, and amino acids.  

Request for a PDF sample of this report: https://www.imarcgroup.com/japan-biocatalyst-market/requestsample

Japan Biocatalyst Market Trends:

The market in Japan is primarily driven by significant growth in biotechnology. Along with this, the growing product utilization as a food enzyme across the food and beverage industry is creating a positive outlook for the market. Also, the rising adoption of modified organism enzymes in plant protein products for achieving a savory taste is further providing a boost to the market growth. Moreover, increasing investments by private and public firms to upgrade the biotechnology infrastructure across Japan are positively influencing the market growth. Some of the other factors contributing to the market growth include extensive research and development (R&D) activities and continuous improvements in the pharmaceutical sector across the country.  

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units Kilo Tons
Segment Coverage Type, Application, Source, Region

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Japan biocatalyst market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on type, application and source.

Breakup by Type:

  • Hydrolases
  • Oxidoreductases
  • Transferases
  • Others

Breakup by Application:

  • Food and Beverage
  • Cleaning Agents
  • Biofuel Production
  • Agriculture and Feed
  • Biopharmaceuticals
  • Others

Breakup by Source:

  • Microorganisms
  • Plants
  • Animal

Breakup by Region:

  • Kanto Region
  • Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/japan-biocatalyst-market

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                             

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800

<< Previous
Bullboard Posts